Pathological complete response to perioperative treatment with darolutamide plus ADT in locally advanced prostate cancer without PTEN or RB1 loss: a case report

Zhihui Zhang, Jiwei Zhai, Qimei Ma, Yuzhu Xiang, Jiajun Kan, Junhao Chu, Chunxiao Wei, Muwen Wang · 2026

Read Pathological complete response to perioperative treatment with darolutamide plus ADT in locally advanced prostate cancer without PTEN or RB1 loss: a case report by Zhihui Zhang, Jiwei Zhai, Qimei Ma, Yuzhu Xiang, Jiajun Kan, Junhao Chu, Chunxiao Wei, Muwen Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13272317.txt.

Description

Zhihui Zhang and coauthors report in 2026 a prostate cancer case where hormone treatment around surgery cleared all detectable cancer from the removed tissue. The 70-year-old patient had locally advanced disease invading the bladder wall and pelvic nodes, with a very high PSA level. His tumor kept two genes, PTEN and RB1, whose loss often predicts hormone resistance.

Treatment paired the androgen blocker darolutamide with a hormone-suppressing injection given every three months. Testosterone fell to castration level within a month, and PSA dropped sharply from its starting value near eighty-nine. The report explores gene status as a guide for choosing intensive hormone therapy before surgery.

Catalog record

CREATORZhihui Zhang, Jiwei Zhai, Qimei Ma, Yuzhu Xiang, Jiajun Kan, Junhao Chu, Chunxiao Wei, Muwen Wang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13272317

Browse the full library · About the Tower of Babel